These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3123184)

  • 21. Clinical comparison of glipizide and glyburide.
    Schmitt JK
    Diabetes Care; 1989 Jan; 12(1):39. PubMed ID: 2496963
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of morning or bedtime insulin with and without glyburide in secondary sulfonylurea failure.
    Soneru IL; Agrawal L; Murphy JC; Lawrence AM; Abraira C
    Diabetes Care; 1993 Jun; 16(6):896-901. PubMed ID: 8325203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect on metabolic control of second-generation sulfonylurea drugs in patients with NIDDM after secondary failure to first-generation agents.
    Sami T; Kabadi UM; Moshiri S
    J Fam Pract; 1996 Oct; 43(4):370-4. PubMed ID: 8874372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of sulfonylurea on glucose, insulin and C-peptide responses to a meal stimulus in a patient with type 2 diabetes and liver disease.
    Ahrén B; Scherstén B
    Acta Med Scand; 1984; 215(5):487-91. PubMed ID: 6430037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of stress on glycemic control in patients with type II diabetes during glyburide and glipizide therapy.
    Jaber LA; Lewis NJ; Slaughter RL; Neale AV
    J Clin Pharmacol; 1993 Mar; 33(3):239-45. PubMed ID: 8463437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glyburide in non-insulin-dependent diabetes. Its therapeutic effect in patients with disease poorly controlled by insulin alone.
    Lardinois CK; Liu GC; Reaven GM
    Arch Intern Med; 1985 Jun; 145(6):1028-32. PubMed ID: 3923961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of primary effect of sulphonylurea (glipizide) on plasma lipoproteins and insulin action in former type 2 diabetics with attenuated insulin secretion.
    Sartor G; Ursing D; Nilsson-Ehle P; Wåhlin-Boll E; Melander A
    Eur J Clin Pharmacol; 1987; 33(3):279-82. PubMed ID: 3319648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin versus glipizide treatment in patients with non-insulin-dependent diabetes mellitus. Effects on blood pressure and glucose tolerance.
    Levy J; Vandenberg M; Grunberger G
    Am J Hypertens; 1995 May; 8(5 Pt 1):445-53. PubMed ID: 7662219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of glipizide on insulin secretion and insulin metabolism in obese type II diabetic patients.
    Bonora E; Pisani F; Micciolo R; Corgnati A; Muggeo M
    Diabetes Care; 1987; 10(6):687-91. PubMed ID: 3322723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of preconstituted, fixed combinations of low-dose glyburide plus metformin versus high-dose glyburide alone in the treatment of type 2 diabetic patients.
    Erle G; Lovise S; Stocchiero C; Lora L; Coppini A; Marchetti P; Merante D
    Acta Diabetol; 1999 Jun; 36(1-2):61-5. PubMed ID: 10436254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism.
    Osei K; O'Dorisio TM; Falko JM
    Am J Med; 1984 Dec; 77(6):1002-9. PubMed ID: 6439036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus.
    Jaber LA; Ducharme MP; Edwards DJ; Slaughter RL; Grunberger G
    Pharmacotherapy; 1996; 16(5):760-8. PubMed ID: 8888072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute actions of sulfonylurea drugs during long-term treatment of NIDDM.
    Faber OK; Beck-Nielsen H; Binder C; Butzer P; Damsgaard EM; Froland F; Hjollund E; Lindskov HO; Melander A; Pedersen O
    Diabetes Care; 1990 Aug; 13 Suppl 3():26-31. PubMed ID: 2120020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of glipizide and glyburide in a health maintenance organization.
    Noyes MA; Carter BL; Helling DK; McCormick WC; Ramirez R
    Ann Pharmacother; 1992 Oct; 26(10):1215-20. PubMed ID: 1421641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
    Chow CC; Tsang LW; Sorensen JP; Cockram CS
    Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of glipizide on early insulin release and glucose disposal before and after dietary regulation in diabetic patients with different degrees of hyperglycaemia.
    Bitzén PO; Melander A; Scherstén B; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1988; 35(1):31-7. PubMed ID: 3065086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of obesity on the pharmacokinetics and pharmacodynamics of glipizide in patients with non-insulin-dependent diabetes mellitus.
    Jaber LA; Ducharme MP; Halapy H
    Ther Drug Monit; 1996 Feb; 18(1):6-13. PubMed ID: 8848822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of glipizide GITS and glibenclamide on metabolic control, hepatic glucose production, and insulin secretion in patients with type 2 diabetes.
    Go EH; Kyriakidou-Himonas M; Berelowitz M
    Diabetes Metab Res Rev; 2004; 20(3):225-31. PubMed ID: 15133754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea.
    Goldstein BJ; Pans M; Rubin CJ
    Clin Ther; 2003 Mar; 25(3):890-903. PubMed ID: 12852706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects and pharmacokinetics of oral glibenclamide and glipizide in Caucasian and Chinese patients with type-2 diabetes.
    Jönsson A; Chan JC; Rydberg T; Vaaler S; Hallengren B; Cockram CS; Critchley JA; Melander A
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):711-4. PubMed ID: 11214781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.